Charles TRUILLET Shares Research Opportunity in Lung Cancer Immunotherapy Resistance @BiomapI oncodaily.com/career/charles…

CRI-Funded Research and Scientific Presentations at SITC 2026 – Cancer Research Institute (CRI) @CancerResearch oncodaily.com/societies/canc…

A New T-Cell Strategy Takes Aim at Advanced Solid Tumors - Kunle Odunsi @KunleOdunsiMD oncodaily.com/science/kunle-…

Tumor Growth vs Antitumor Immunity, A New Strategy to Fight MSS Colorectal Cancer - Victor Moreno @VicMorenoGarcia oncodaily.com/science/colore…

SITC and ESMO Announce Joint Primer Program for December 2026 @sitcancer @myESMO oncodaily.com/societies/sitc…

David Raben Begins New Chapter at Pliant Therapeutics as Chief Medical Officer @PliantRX oncodaily.com/career/david-r…

Presenting New Biomarker Findings in Melanoma Immunotherapy at Society for Immunotherapy of Cancer (SITC) - Lisa Ebert @lisamebert @sitcancer oncodaily.com/science/lisa-e…

Dark Proteome Cancer Vaccines Expanding the Horizon of Immunotherapy - Bernard A. Fox @BernardAFox oncodaily.com/science/bernar…

FDA Clears First-in-Human CLEC2A-Directed CAR T-Cell Trial - Soheil Meshinchi MD., Ph.D. @mshadman oncodaily.com/science/soheil…

DAVID MORENO DELGADO on ATALANTA-1: 7-Day Vein to Vein, but Does Fresh CAR-T Add Value? @ucb_news oncodaily.com/science/david-…

New INMC Analysis Reports Five-Year Outcomes of Neoadjuvant Therapy in Melanoma - Andrea Boutros @boutrosand oncodaily.com/science/andrea…

Cancer Vaccines: A Defining Moment for Cancer Patients – Parker Institute for Cancer Immunotherapy @parkerici oncodaily.com/voices/pici-60…

A New T Cell Strategy for Early Lung Cancer Interception - James Reading @JL_Reading oncodaily.com/new-paper-aler…

Neoadjuvant Immunotherapy Is Here to Stay - Manushak Avagyan @sitcancer oncodaily.com/voices/manusha…

Ivonescimab Shows an Overall Survival Benefit Over Pembrolizumab in NSCLC - Tanja Obradovic @HopeAI_Org oncodaily.com/new-paper-aler…

Can Immunotherapy Find a Role In HR+ Metastatic Breast Cancer? - Matthew Kurian @MatthewKurianMD oncodaily.com/science/matthe…

Andrea Boutros: Exploring Chronic Toxicity After Adjuvant Anti-PD-1 for Melanoma @boutrosand oncodaily.com/science/andrea…

Unraveling the Mechanisms Behind Allogeneic CAR-T Rejection and Expansion - Yan Leyfman (@YLeyfman) oncodaily.com/voices/yan-ley…

Growing Role of Immune Checkpoint Therapy in Pediatric and Adolescent Lymphoma - Vera Ghali @veraghali oncodaily.com/science/vera-g…

Marengo Therapeutics to Present STARt-002 Phase 2 Results at SITC 2026 - Zhen Su, MD MBA @MyOncology @sitcancer oncodaily.com/voices/zhen-su…